Considering their expression patterns in DS and breast and lung cancers, as well as their co-expression in these cancers, we hypothesize that ETS2 and RCAN1 are at least partly responsible for the low incidences of breast and lung cancers in DS. This evidence concerns the gene ETS2 and lung carcinoma.